|
Therapeutic Antibodies Europe 2010 Conference will provide a forum for leading industry experts from major pharmaceutical companies. They would get an chance to discuss and evaluate the latest challenges and problems facing the therapeutic antibodies sector. The conference will enable attendees to learn about the latest technological developments, testing issues and the engineering of future antibody generations. Therapeutic Antibodies Europe 2010 will comprise of key note presentation from the most important pharmaceutical and biotech companies in the antibody market. It will also feature best case studies on the most recent antibody improvements. It is a must-attend event and will provide an excellent opportunity to network, enhance company’s profile and stay competitive.
The conference will focus on the topics mentioned below:
- Strategies for optimising current and future therapeutic antibodies
- Antibodies for infectious diseases and oncology
- Current and future market landscape
- Protein development, production and purification
- Next generation antibodies, scaffolds, peptides, drug conjugates
Visitor Profile
The targeted visitors at the Therapeutic Antibodies Europe 2010 would include VP’s and Directors associated with:
- Principle Scientists
- R&D
- CSO’s
- Senior Scientists
- Biopharmaceuticals
- Drug Development
- Drug Discovery
Organizer
The Ideas Exchange Ltd